These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry. Cañete F; Mañosa M; Casanova MJ; González-Sueyro RC; Barrio J; Bermejo F; Nos P; Iglesias-Flores E; García-Planella E; Pérez-Calle JL; Vicente R; Vera M; Ramos L; Rivero M; De Francisco R; Montserrat A; Benítez O; Navarro P; Taxonera C; Hinojosa E; Márquez-Mosquera L; Navarro-Llavat M; Ramírez-de la Piscina P; Gomollón F; Rodríguez-Alonso L; Núñez-Alonso A; Fernández-Salazar L; Almela P; Ríos León R; De Castro L; Gisbert JP; Ricart E; Cabré E; Domènech E; Inflamm Bowel Dis; 2019 Oct; 25(11):1862-1870. PubMed ID: 31006801 [TBL] [Abstract][Full Text] [Related]
23. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. Afzali A; Wheat CL; Hu JK; Olerud JE; Lee SD J Crohns Colitis; 2014 Jun; 8(6):480-8. PubMed ID: 24268978 [TBL] [Abstract][Full Text] [Related]
24. Comparative effectiveness of anti-TNF agents for Crohn's disease in a tertiary referral IBD practice. Patil SA; Rustgi A; Langenberg P; Cross RK Dig Dis Sci; 2013 Jan; 58(1):209-15. PubMed ID: 23014844 [TBL] [Abstract][Full Text] [Related]
25. Mucosal healing and anti TNFs in IBD. van Assche G; Vermeire S; Rutgeerts P Curr Drug Targets; 2010 Feb; 11(2):227-33. PubMed ID: 20210770 [TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics. Inokuchi T; Takahashi S; Hiraoka S; Toyokawa T; Takagi S; Takemoto K; Miyaike J; Fujimoto T; Higashi R; Morito Y; Nawa T; Suzuki S; Nishimura M; Inoue M; Kato J; Okada H J Gastroenterol Hepatol; 2019 Aug; 34(8):1329-1336. PubMed ID: 30724387 [TBL] [Abstract][Full Text] [Related]
27. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]
28. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease. Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629 [TBL] [Abstract][Full Text] [Related]
29. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis. Cañete F; Mañosa M; Pérez-Martínez I; Barreiro-de Acosta M; González-Sueyro RC; Nos P; Iglesias-Flores E; Gutiérrez A; Bujanda L; Gordillo J; Ríos León R; Casanova MJ; Villoria A; Rodríguez-Lago I; López Serrano P; García-Herola A; Ramírez-de la Piscina P; Navarro-Llavat M; Taxonera C; Barrio J; Ramos L; Navarro P; Benítez-Leiva O; Calafat M; Domènech E; Clin Transl Gastroenterol; 2020 Aug; 11(8):e00218. PubMed ID: 32955190 [TBL] [Abstract][Full Text] [Related]
30. Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review. Scribano ML; Cantoro L; Marrollo M; Cosintino R; Kohn A J Clin Gastroenterol; 2014 Jul; 48(6):530-3. PubMed ID: 24667589 [TBL] [Abstract][Full Text] [Related]
31. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease. Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527 [TBL] [Abstract][Full Text] [Related]
32. Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis. Faleck DM; Shmidt E; Huang R; Katta LG; Narula N; Pinotti R; Suarez-Farinas M; Colombel JF Clin Gastroenterol Hepatol; 2021 Feb; 19(2):238-245.e4. PubMed ID: 32569749 [TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers. Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857 [TBL] [Abstract][Full Text] [Related]